Home
>
US Stocks
>
Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc
FULC

Fulcrum Therapeutics Inc

$261.55%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
27.4
Today Low/High
25.86 / 27.4
52 Week Low/High
$6.85 / $25.56
Market Cap
$714.35M

Company Details

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum's proprietary product engine identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum has also advanced FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and beta thalassemia into Phase 1 clinical development.
Organisation
Fulcrum Therapeutics Inc
Employees
73
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Fulcrum Therapeutics Inc share price today

Can Indians buy Fulcrum Therapeutics Inc shares?

How can I buy Fulcrum Therapeutics Inc shares from India?

Can Fractional shares of Fulcrum Therapeutics Inc be purchased?

What are the documents required to start investing in Fulcrum Therapeutics Inc stocks?

We are a SEBI registered investement advisor